Ablation Devices Global Market - Forecast to 2023
Ablation is the minimally invasive therapeutic tissue excision procedure used for a wide range of purposes, from cancerous or diseased tissue removal, to the removal of abnormally conducting cardiac tissue in atrial fibrillation and others. The growing adoption of minimally invasive procedures is pushing the researchers to innovate and improvise existing ablation technologies for better patient care.
The ablation device global market is expected to grow at high single digit CAGR to reach $20,995.5 million by 2023. The ablation device global market by technology is segmented into thermal ablation and non thermal ablation. The thermal ablation technologies are radiation therapy, cryoablation, radiofrequency, laser, ultrasound, microwave, and hydrothermal ablation technology. Among thermal ablation, radiofrequency ablation accounted for the largest share in 2016 and microwave is expected to grow at highest CAGR from 2016-2023. Non thermal technology includes electroporation, mechanical ablation and others (Chemical). Among non thermal ablation technologies, electroporation generated the largest share in 2016, and is expected to grow at a mid single digit CAGR from 2016-2023.
By application, the ablation device global market is segmented oncology, cardiovascular diseases, ophthalmology, cosmetology, gynaecology, general surgery, urology, orthopaedics, pain management and others. Atrial Fibrilation, Ventricular Tachycardia and Others are the segments in cardiovascular application. Oncology is holding the largest revenue in 2016 and cardiovascular application is expected to grow at a high CAGR from 2016-2023.
By end-users, the market is segmented into hospitals, ambulatory surgical centres and speciality clinics. Hospitals generated the largest revenue in 2016 and are expected to grow at high CAGR from 2016-2023
By geography, the market is segmented into North America, Europe, Asia-Pacific and Rest of World. North America holds the largest market share in 2016, followed by Europe and Asia. The APAC regions tend to be an emerging market with an opportunity for growth with a highest CAGR from 2016-2023 and are likely to be a destination of investment for new investors in the ablation device market.
The ablation device market is expected to grow at high single digit CAGR from 2016-2023. The major factor influencing the growth are increasing number of ablation procedures, rising incidence of cancer, emergence of next-generation ablation products and technologies, growing adoption of minimally invasive procedures, and improving reimbursement scenario in established markets are some of the factors driving the market. However, reuse and reprocessing of devices in developing countries, healthcare cost-containment measures, stringent regulatory guidelines, and challenges in therapeutic procedures are some of the factors hampering the market.
The ablation device global market is a competitive and all the active players in this market are involved in innovating new and advanced products to maintain their market shares. The key players in the ablation device global market include Boston Scientific Corporation (U.S.), Johnson and Johnson (U.S.), Abbott laboratories (St Jude Medical) (U.S.), Medtronic (Ireland), Stryker Corporation (U.S.), Elekta AB (Sweden), Olympus Corporation (Japan), ConMed Corporation (U.S.), Hologic (U.S.), Articure Inc. (U.S.), Angiodynamics Inc. (U.S.), Smith and Nephew plc (U.K.), and Varian Medical Systems (U.S.).
The report provides an in depth market analysis of the above mentioned segments across the following regions:
The ablation device global market is expected to grow at high single digit CAGR to reach $20,995.5 million by 2023. The ablation device global market by technology is segmented into thermal ablation and non thermal ablation. The thermal ablation technologies are radiation therapy, cryoablation, radiofrequency, laser, ultrasound, microwave, and hydrothermal ablation technology. Among thermal ablation, radiofrequency ablation accounted for the largest share in 2016 and microwave is expected to grow at highest CAGR from 2016-2023. Non thermal technology includes electroporation, mechanical ablation and others (Chemical). Among non thermal ablation technologies, electroporation generated the largest share in 2016, and is expected to grow at a mid single digit CAGR from 2016-2023.
By application, the ablation device global market is segmented oncology, cardiovascular diseases, ophthalmology, cosmetology, gynaecology, general surgery, urology, orthopaedics, pain management and others. Atrial Fibrilation, Ventricular Tachycardia and Others are the segments in cardiovascular application. Oncology is holding the largest revenue in 2016 and cardiovascular application is expected to grow at a high CAGR from 2016-2023.
By end-users, the market is segmented into hospitals, ambulatory surgical centres and speciality clinics. Hospitals generated the largest revenue in 2016 and are expected to grow at high CAGR from 2016-2023
By geography, the market is segmented into North America, Europe, Asia-Pacific and Rest of World. North America holds the largest market share in 2016, followed by Europe and Asia. The APAC regions tend to be an emerging market with an opportunity for growth with a highest CAGR from 2016-2023 and are likely to be a destination of investment for new investors in the ablation device market.
The ablation device market is expected to grow at high single digit CAGR from 2016-2023. The major factor influencing the growth are increasing number of ablation procedures, rising incidence of cancer, emergence of next-generation ablation products and technologies, growing adoption of minimally invasive procedures, and improving reimbursement scenario in established markets are some of the factors driving the market. However, reuse and reprocessing of devices in developing countries, healthcare cost-containment measures, stringent regulatory guidelines, and challenges in therapeutic procedures are some of the factors hampering the market.
The ablation device global market is a competitive and all the active players in this market are involved in innovating new and advanced products to maintain their market shares. The key players in the ablation device global market include Boston Scientific Corporation (U.S.), Johnson and Johnson (U.S.), Abbott laboratories (St Jude Medical) (U.S.), Medtronic (Ireland), Stryker Corporation (U.S.), Elekta AB (Sweden), Olympus Corporation (Japan), ConMed Corporation (U.S.), Hologic (U.S.), Articure Inc. (U.S.), Angiodynamics Inc. (U.S.), Smith and Nephew plc (U.K.), and Varian Medical Systems (U.S.).
The report provides an in depth market analysis of the above mentioned segments across the following regions:
- North America
- Europe
- Asia-Pacific
- Rest of the World (RoW)
1 EXECUTIVE SUMMARY
2 INTRODUCTION
2.1 KEY TAKE AWAYS
2.2 REPORT DESCRIPTION
2.3 MARKETS COVERED
2.4 STAKEHOLDERS
2.5 RESEARCH METHODOLOGY
2.5.1 MARKET SIZE ESTIMATION
2.5.2 MARKET BREAKDOWN & DATA TRIANGULATION
2.5.3 SECONDARY SOURCES
2.5.4 KEY DATA POINTS FROM SECONDARY SOURCES
2.5.5 PRIMARY SOURCES
2.5.6 KEY DATA POINTS FROM PRIMARY SOURCES
2.5.7 ASSUMPTIONS
3 MARKET ANALYSIS
3.1 INTRODUCTION
3.2 MARKET SEGMENTATION
3.3 FACTORS INFLUENCING MARKET
3.3.1 DRIVERS AND OPPORTUNITIES
3.3.1.1 Increasing Aging Population
3.3.1.2 Rising Incidence of Cancer and Cardiovascular Diseases
3.3.1.3 Growing Adoption of Minimally Invasive Procedures
3.3.1.4 Improving Reimbursement Scenario In Established Markets
3.3.1.5 Emergence of Next-Generation Ablation Products and Technologies
3.3.1.6 Increasing Number of Ablation Procedures
3.3.1.7 Increasing Funding for the Development of Novel Ablation Device
3.3.1.8 Emerging APAC Markets
3.3.2 RESTRAINTS & THREATS
3.3.2.1 Reuse And Reprocessing of Devices in Developing Countries
3.3.2.2 Healthcare Cost Containment Measures
3.3.2.3 Stringent Regulatory Approvals
3.3.2.4 Challenges in Therapeutic Procedures
3.4 UPCOMING TECHNOLOGY
3.5 REIMBURSEMENT
3.6 REGULATORY AFFAIRS
3.6.1 U.S.
3.6.2 EUROPE
3.6.3 INDIA
3.6.4 CHINA
3.6.5 JAPAN
3.7 PATENT TRENDS
3.8 SUPPLY CHAIN ANALYSIS
3.9 PORTER’S FIVE FORCE ANALYSIS
3.9.1 THREAT OF NEW ENTRANTS
3.9.2 THREAT OF SUBSTITUTES
3.9.3 BARGAINING POWER OF SUPPLIERS
3.9.4 BARGAINING POWER OF BUYERS
3.9.5 RIVALRY AMONG EXISTING COMPETITORS
3.10 MARKET SHARE ANALYSIS
3.10.1 MARKET SHARE ANALYSIS BY ABLATION DEVICE MAJOR PLAYERS
3.10.2 MARKET SHARE ANALYSIS BY ATRIAL FIBRILLATION ABLATION DEVICE MAJOR PLAYERS
3.10.3 MARKET SHARE ANALYSIS BY RADIATION ABLATION DEVICE MAJOR PLAYERS
4 ABLATION DEVICES GLOBAL MARKET, BY TECHNOLOGY
4.1 INTRODUCTION
4.2 THERMAL ABLATION
4.2.1 RADIOFREQUENCY ABLATION
4.2.2 LASER ABLATION TECHNOLOGY
4.2.3 MICROWAVE ABLATION TECHNOLOGY
4.2.4 ULTRASOUND ABLATION TECHNOLOGY
4.2.5 RADIATION ABLATION TECHNOLOGY
4.2.6 CRYOABLATION TECHNOLOGY
4.2.7 HYDROTHERMAL ABLATION TECHNOLOGY
4.3 NON-THERMAL TECHNOLOGY BASED ABLATION
4.3.1 ELECTROPORATION ABLATION TECHNOLOGY
4.3.2 MECHANICAL ABLATION TECHNOLOGY
4.3.3 OTHERS
5 ABLATION DEVICES GLOBAL MARKET, BY APPLICATION
5.1 INTRODUCTION
5.2 ONCOLOGY
5.3 CARDIOVASCULAR
5.3.1 ATRIAL FIBRILATION (AF/AFIB)
5.3.2 VENTRICULAR TACHYCARDIA (VT)
5.3.3 OTHERS
5.4 OPHTHALMOLOGY
5.5 COSMETOLOGY
5.6 GYNECOLOGY
5.7 GENERAL SURGERY
5.8 UROLOGY
5.9 ORTHOPEDICS
5.10 PAIN MANAGEMENT
5.11 OTHER
6 ABLATION DEVICES GLOBAL MARKET, BY END-USERS
6.1 INTRODUCTION
6.2 HOSPITALS
6.3 AMBULATORY SURGICAL CENTRES
6.4 SPECIALITY CLINICS
7 REGIONAL MARKET ANALYSIS
7.1 INTRODUCTION
7.2 NORTH AMERICA
7.2.1 U.S.
7.2.2 OTHERS
7.3 EUROPE
7.3.1 U.K.
7.3.2 GERMANY
7.3.3 FRANCE
7.3.4 OTHERS
7.4 ASIA PACIFIC
7.4.1 INDIA
7.4.2 CHINA
7.4.3 JAPAN
7.4.4 OTHERS
7.5 REST OF THE WORLD
7.5.1 MIDDLE EAST
7.5.2 BRAZIL
7.5.3 OTHERS
8 COMPANY DEVELOPMENTS
8.1 INTRODUCTION
8.1.1 MERGER AND ACQUISITION AS A MAJOR GROWTH STRATEGY OF ABLATION DEVICE MARKET PLAYERS
8.2 MERGERS AND ACQUISITIONS
8.3 APPROVAL
8.4 NEW PRODUCT LAUNCH
8.5 AGREEMENTS PARTNERSHIPS, COLLABORATIONS & JOINT VENTURES
8.6 BUSINESS EXPANSION
9 MAJOR PLAYER PROFILES
9.1 ABBOTT LABORATORIES (ST JUDE MEDICAL)
9.1.1 OVERVIEW
9.1.2 FINANCIALS
9.1.3 PRODUCT PORTFOLIO
9.1.4 KEY DEVELOPMENTS
9.1.5 BUSINESS STRATEGY
9.1.6 SWOT ANALYSIS
9.2 ANGIODYNAMICS INC.
9.2.1 OVERVIEW
9.2.2 FINANCIALS
9.2.3 PRODUCT PORTFOLIO
9.2.4 KEY DEVELOPMENTS
9.2.5 BUSINESS STRATEGY
9.2.6 SWOT ANALYSIS
9.3 ARTICURE INC.
9.3.1 OVERVIEW
9.3.2 FINANCIALS
9.3.3 PRODUCT PORTFOLIO
9.3.4 KEY DEVELOPMENTS
9.3.5 BUSINESS STRATEGY
9.3.6 SWOT ANALYSIS
9.4 BOSTON SCIENTIFIC CORPORATION
9.4.1 OVERVIEW
9.4.2 FINANCIALS
9.4.3 PRODUCT PORTFOLIO
9.4.4 KEY DEVELOPMENTS
9.4.5 BUSINESS STRATEGY
9.4.6 SWOT ANALYSIS
9.5 CONMED CORPORATION
9.5.1 OVERVIEW
9.5.2 FINANCIALS
9.5.3 PRODUCT PORTFOLIO
9.5.4 KEY DEVELOPMENTS
9.5.5 BUSINESS STRATEGY
9.5.6 SWOT ANALYSIS
9.6 ELEKTA AB
9.6.1 OVERVIEW
9.6.2 FINANCIALS
9.6.3 PRODUCT PORTFOLIO
9.6.4 KEY DEVELOPMENTS
9.6.5 BUSINESS STRATEGY
9.6.6 SWOT ANALYSIS
9.7 HOLOGIC INC.
9.7.1 OVERVIEW
9.7.2 FINANCIALS
9.7.3 PRODUCT PORTFOLIO
9.7.4 KEY DEVELOPMENTS
9.7.5 BUSINESS STRATEGY
9.7.6 SWOT ANALYSIS
9.8 JOHNSON & JOHNSON
9.8.1 OVERVIEW
9.8.2 FINANCIALS
9.8.3 PRODUCT PORTFOLIO
9.8.4 KEY DEVELOPMENTS
9.8.5 BUSINESS STRATEGY
9.8.6 SWOT ANALYSIS
9.9 MEDTRONIC, PLC
9.9.1 OVERVIEW
9.9.2 FINANCIALS
9.9.3 PRODUCT PORTFOLIO
9.9.4 KEY DEVELOPMENTS
9.9.5 BUSINESS STRATEGY
9.9.6 SWOT ANALYSIS
9.10 OLYMPUS CORPORATION
9.10.1 OVERVIEW
9.10.2 FINANCIALS
9.10.3 PRODUCT PORTFOLIO
9.10.4 KEY DEVELOPMENTS
9.10.5 BUSINESS STRATEGY
9.10.6 SWOT ANALYSIS
9.11 SMITH & NEPHEW PLC
9.11.1 OVERVIEW
9.11.2 FINANCIALS
9.11.3 PRODUCT PORTFOLIO
9.11.4 KEY DEVELOPMENTS
9.11.5 BUSINESS STRATEGY
9.11.6 SWOT ANALYSIS
9.12 STRYKER CORPORATION
9.12.1 OVERVIEW
9.12.2 FINANCIALS
9.12.3 PRODUCT PORTFOLIO
9.12.4 KEY DEVELOPMENTS
9.12.5 BUSINESS STRATEGY
9.12.6 SWOT ANALYSIS
9.13 VARIAN MEDICAL SYSTEMS
9.13.1 OVERVIEW
9.13.2 FINANCIALS
9.13.3 PRODUCT PORTFOLIO
9.13.4 KEY DEVELOPMENTS
9.13.5 BUSINESS STRATEGY
9.13.6 SWOT ANALYSIS
2 INTRODUCTION
2.1 KEY TAKE AWAYS
2.2 REPORT DESCRIPTION
2.3 MARKETS COVERED
2.4 STAKEHOLDERS
2.5 RESEARCH METHODOLOGY
2.5.1 MARKET SIZE ESTIMATION
2.5.2 MARKET BREAKDOWN & DATA TRIANGULATION
2.5.3 SECONDARY SOURCES
2.5.4 KEY DATA POINTS FROM SECONDARY SOURCES
2.5.5 PRIMARY SOURCES
2.5.6 KEY DATA POINTS FROM PRIMARY SOURCES
2.5.7 ASSUMPTIONS
3 MARKET ANALYSIS
3.1 INTRODUCTION
3.2 MARKET SEGMENTATION
3.3 FACTORS INFLUENCING MARKET
3.3.1 DRIVERS AND OPPORTUNITIES
3.3.1.1 Increasing Aging Population
3.3.1.2 Rising Incidence of Cancer and Cardiovascular Diseases
3.3.1.3 Growing Adoption of Minimally Invasive Procedures
3.3.1.4 Improving Reimbursement Scenario In Established Markets
3.3.1.5 Emergence of Next-Generation Ablation Products and Technologies
3.3.1.6 Increasing Number of Ablation Procedures
3.3.1.7 Increasing Funding for the Development of Novel Ablation Device
3.3.1.8 Emerging APAC Markets
3.3.2 RESTRAINTS & THREATS
3.3.2.1 Reuse And Reprocessing of Devices in Developing Countries
3.3.2.2 Healthcare Cost Containment Measures
3.3.2.3 Stringent Regulatory Approvals
3.3.2.4 Challenges in Therapeutic Procedures
3.4 UPCOMING TECHNOLOGY
3.5 REIMBURSEMENT
3.6 REGULATORY AFFAIRS
3.6.1 U.S.
3.6.2 EUROPE
3.6.3 INDIA
3.6.4 CHINA
3.6.5 JAPAN
3.7 PATENT TRENDS
3.8 SUPPLY CHAIN ANALYSIS
3.9 PORTER’S FIVE FORCE ANALYSIS
3.9.1 THREAT OF NEW ENTRANTS
3.9.2 THREAT OF SUBSTITUTES
3.9.3 BARGAINING POWER OF SUPPLIERS
3.9.4 BARGAINING POWER OF BUYERS
3.9.5 RIVALRY AMONG EXISTING COMPETITORS
3.10 MARKET SHARE ANALYSIS
3.10.1 MARKET SHARE ANALYSIS BY ABLATION DEVICE MAJOR PLAYERS
3.10.2 MARKET SHARE ANALYSIS BY ATRIAL FIBRILLATION ABLATION DEVICE MAJOR PLAYERS
3.10.3 MARKET SHARE ANALYSIS BY RADIATION ABLATION DEVICE MAJOR PLAYERS
4 ABLATION DEVICES GLOBAL MARKET, BY TECHNOLOGY
4.1 INTRODUCTION
4.2 THERMAL ABLATION
4.2.1 RADIOFREQUENCY ABLATION
4.2.2 LASER ABLATION TECHNOLOGY
4.2.3 MICROWAVE ABLATION TECHNOLOGY
4.2.4 ULTRASOUND ABLATION TECHNOLOGY
4.2.5 RADIATION ABLATION TECHNOLOGY
4.2.6 CRYOABLATION TECHNOLOGY
4.2.7 HYDROTHERMAL ABLATION TECHNOLOGY
4.3 NON-THERMAL TECHNOLOGY BASED ABLATION
4.3.1 ELECTROPORATION ABLATION TECHNOLOGY
4.3.2 MECHANICAL ABLATION TECHNOLOGY
4.3.3 OTHERS
5 ABLATION DEVICES GLOBAL MARKET, BY APPLICATION
5.1 INTRODUCTION
5.2 ONCOLOGY
5.3 CARDIOVASCULAR
5.3.1 ATRIAL FIBRILATION (AF/AFIB)
5.3.2 VENTRICULAR TACHYCARDIA (VT)
5.3.3 OTHERS
5.4 OPHTHALMOLOGY
5.5 COSMETOLOGY
5.6 GYNECOLOGY
5.7 GENERAL SURGERY
5.8 UROLOGY
5.9 ORTHOPEDICS
5.10 PAIN MANAGEMENT
5.11 OTHER
6 ABLATION DEVICES GLOBAL MARKET, BY END-USERS
6.1 INTRODUCTION
6.2 HOSPITALS
6.3 AMBULATORY SURGICAL CENTRES
6.4 SPECIALITY CLINICS
7 REGIONAL MARKET ANALYSIS
7.1 INTRODUCTION
7.2 NORTH AMERICA
7.2.1 U.S.
7.2.2 OTHERS
7.3 EUROPE
7.3.1 U.K.
7.3.2 GERMANY
7.3.3 FRANCE
7.3.4 OTHERS
7.4 ASIA PACIFIC
7.4.1 INDIA
7.4.2 CHINA
7.4.3 JAPAN
7.4.4 OTHERS
7.5 REST OF THE WORLD
7.5.1 MIDDLE EAST
7.5.2 BRAZIL
7.5.3 OTHERS
8 COMPANY DEVELOPMENTS
8.1 INTRODUCTION
8.1.1 MERGER AND ACQUISITION AS A MAJOR GROWTH STRATEGY OF ABLATION DEVICE MARKET PLAYERS
8.2 MERGERS AND ACQUISITIONS
8.3 APPROVAL
8.4 NEW PRODUCT LAUNCH
8.5 AGREEMENTS PARTNERSHIPS, COLLABORATIONS & JOINT VENTURES
8.6 BUSINESS EXPANSION
9 MAJOR PLAYER PROFILES
9.1 ABBOTT LABORATORIES (ST JUDE MEDICAL)
9.1.1 OVERVIEW
9.1.2 FINANCIALS
9.1.3 PRODUCT PORTFOLIO
9.1.4 KEY DEVELOPMENTS
9.1.5 BUSINESS STRATEGY
9.1.6 SWOT ANALYSIS
9.2 ANGIODYNAMICS INC.
9.2.1 OVERVIEW
9.2.2 FINANCIALS
9.2.3 PRODUCT PORTFOLIO
9.2.4 KEY DEVELOPMENTS
9.2.5 BUSINESS STRATEGY
9.2.6 SWOT ANALYSIS
9.3 ARTICURE INC.
9.3.1 OVERVIEW
9.3.2 FINANCIALS
9.3.3 PRODUCT PORTFOLIO
9.3.4 KEY DEVELOPMENTS
9.3.5 BUSINESS STRATEGY
9.3.6 SWOT ANALYSIS
9.4 BOSTON SCIENTIFIC CORPORATION
9.4.1 OVERVIEW
9.4.2 FINANCIALS
9.4.3 PRODUCT PORTFOLIO
9.4.4 KEY DEVELOPMENTS
9.4.5 BUSINESS STRATEGY
9.4.6 SWOT ANALYSIS
9.5 CONMED CORPORATION
9.5.1 OVERVIEW
9.5.2 FINANCIALS
9.5.3 PRODUCT PORTFOLIO
9.5.4 KEY DEVELOPMENTS
9.5.5 BUSINESS STRATEGY
9.5.6 SWOT ANALYSIS
9.6 ELEKTA AB
9.6.1 OVERVIEW
9.6.2 FINANCIALS
9.6.3 PRODUCT PORTFOLIO
9.6.4 KEY DEVELOPMENTS
9.6.5 BUSINESS STRATEGY
9.6.6 SWOT ANALYSIS
9.7 HOLOGIC INC.
9.7.1 OVERVIEW
9.7.2 FINANCIALS
9.7.3 PRODUCT PORTFOLIO
9.7.4 KEY DEVELOPMENTS
9.7.5 BUSINESS STRATEGY
9.7.6 SWOT ANALYSIS
9.8 JOHNSON & JOHNSON
9.8.1 OVERVIEW
9.8.2 FINANCIALS
9.8.3 PRODUCT PORTFOLIO
9.8.4 KEY DEVELOPMENTS
9.8.5 BUSINESS STRATEGY
9.8.6 SWOT ANALYSIS
9.9 MEDTRONIC, PLC
9.9.1 OVERVIEW
9.9.2 FINANCIALS
9.9.3 PRODUCT PORTFOLIO
9.9.4 KEY DEVELOPMENTS
9.9.5 BUSINESS STRATEGY
9.9.6 SWOT ANALYSIS
9.10 OLYMPUS CORPORATION
9.10.1 OVERVIEW
9.10.2 FINANCIALS
9.10.3 PRODUCT PORTFOLIO
9.10.4 KEY DEVELOPMENTS
9.10.5 BUSINESS STRATEGY
9.10.6 SWOT ANALYSIS
9.11 SMITH & NEPHEW PLC
9.11.1 OVERVIEW
9.11.2 FINANCIALS
9.11.3 PRODUCT PORTFOLIO
9.11.4 KEY DEVELOPMENTS
9.11.5 BUSINESS STRATEGY
9.11.6 SWOT ANALYSIS
9.12 STRYKER CORPORATION
9.12.1 OVERVIEW
9.12.2 FINANCIALS
9.12.3 PRODUCT PORTFOLIO
9.12.4 KEY DEVELOPMENTS
9.12.5 BUSINESS STRATEGY
9.12.6 SWOT ANALYSIS
9.13 VARIAN MEDICAL SYSTEMS
9.13.1 OVERVIEW
9.13.2 FINANCIALS
9.13.3 PRODUCT PORTFOLIO
9.13.4 KEY DEVELOPMENTS
9.13.5 BUSINESS STRATEGY
9.13.6 SWOT ANALYSIS
LIST OF TABLES
Table 1 ABLATION DEVICES GLOBAL MARKET REVENUE, BY REGION, (2015-2023) ($MN)
Table 2 ABLATION DEVICES GLOBAL MARKET REVENUE, BY TECHNOLOGY, (2015-2023) ($MN)
Table 3 ABLATION DEVICES GLOBAL MARKET, BY APPLICATION (2015-2023) ($MN)
Table 4 ABLATION DEVICES GLOBAL MARKET REVENUE, BY END-USER, (2015-2023) ($MN)
Table 5 ABLATION DEVICE TECHNIQUES GLOBAL MARKET REVENUE, BY REGION, (2015-2023) ($MN)
Table 6 ABLATION DEVICE GLOBAL MARKET REVENUE, BY TECHNOLOGY, (2015-2023) ($MN)
Table 7 THERMAL TECHNOLOGY IN ABLATION DEVICE GLOBAL MARKET REVENUE, BY REGION, (2015-2023) ($MN)
Table 8 THERMAL TECHNOLOGY IN ABLATION DEVICE GLOBAL MARKET REVENUE, BY TYPES, (2015-2023) ($MN)
Table 9 RADIOFREQUENCY TECHNOLOGY IN ABLATION DEVICE GLOBAL MARKET REVENUE, BY REGION, (2015-2023) ($MN)
Table 10 LASER TECHNOLOGY IN ABLATION DEVICE GLOBAL MARKET REVENUE, BY REGION, (2015-2023) ($MN)
Table 11 MICROWAVE TECHNOLOGY IN ABLATION DEVICE GLOBAL MARKET REVENUE, BY REGION, (2015-2023) ($MN)
Table 12 ULTRASOUND TECHNOLOGY IN ABLATION DEVICE GLOBAL MARKET REVENUE, BY REGION, (2015-2023) ($MN)
Table 13 RADIATION TECHNOLOGY IN ABLATION DEVICE GLOBAL MARKET REVENUE, BY REGION, (2015-2023) ($MN)
Table 14 CRYOABLATION TECHNOLOGY IN ABLATION DEVICE GLOBAL MARKET REVENUE, BY REGION, (2015-2023) ($MN)
Table 15 HYDROTHERMAL TECHNOLOGY IN ABLATION DEVICE GLOBAL MARKET REVENUE, BY REGION, (2015-2023) ($MN)
Table 16 NON-THERMAL TECHNOLOGY IN ABLATION DEVICE GLOBAL MARKET REVENUE, BY REGION, (2015-2023) ($MN)
Table 17 NON-THERMAL TECHNOLOGY IN ABLATION DEVICE GLOBAL MARKET REVENUE, BY TYPE, (2015-2023) ($MN)
Table 18 ELECTROPORATION TECHNOLOGY IN ABLATION DEVICE GLOBAL MARKET REVENUE, BY REGION, (2015-2023) ($MN)
Table 19 MECHANICAL TECHNOLOGY IN ABLATION DEVICE GLOBAL MARKET REVENUE, BY REGION, (2015-2023) ($MN)
Table 20 OTHER NON-THERMAL TECHNOLOGIES IN ABLATION DEVICE GLOBAL MARKET REVENUE, BY REGION, (2015-2023) ($MN)
Table 21 ABLATION DEVICES GLOBAL MARKET, BY APPLICATION (2015-2023) ($MN)
Table 22 ONCOLOGY APPLICATION OF ABLATION DEVICE GLOBAL MARKET REVENUE, BY REGION, (2015-2023) ($MN)
Table 23 CARDIOVASCULAR APPLICATION OF ABLATION DEVICE GLOBAL MARKET REVENUE, BY REGION, (2015-2023) ($MN)
Table 24 CARDIOVASCULAR APPLICATION OF ABLATION DEVICE GLOBAL MARKET, BY TYPES(2015-2023) ($MN)
Table 25 ATRIAL FIBRILATION ABLATION DEVICE GLOBAL MARKET REVENUE, BY REGION, (2015-2023) ($MN)
Table 26 ATRIAL FIBRILATION PROCEDURAL VOLUME GLOBAL MARKET, BY REGION, (2015-2023) (NO'S)
Table 27 VENTRICULAR TACHYCARDIA ABLATION DEVICE GLOBAL MARKET REVENUE, BY REGION, (2015-2023) ($MN)
Table 28 VENTRICULAR TACHYCARDIA PROCEDURAL VOLUME GLOBAL MARKET, BY REGION, (2015-2023) (NO'S)
Table 29 OTHER CARDIOVASCULAR ABLATION DEVICE GLOBAL MARKET REVENUE, BY REGION, (2015-2023) ($MN)
Table 30 OTHER CARDIOVASULAR PROCEDURAL VOLUME GLOBAL MARKET, BY REGION, (2015-2023) (NO'S)
Table 31 OPHTHALMOLOGY APPLICATION OF ABLATION DEVICE GLOBAL MARKET REVENUE, BY REGION, (2015-2023) ($MN)
Table 32 COSMETOLOGY APPLICATION OF ABLATION DEVICE GLOBAL MARKET REVENUE, BY REGION, (2015-2023) ($MN)
Table 33 GYNECOLOGY APPLICATION OF ABLATION DEVICE GLOBAL MARKET, BY REGION (2015-2023) ($MN)
Table 34 GENERAL SURGERY APPLICATION OF ABLATION DEVICE GLOBAL MARKET, BY REGION (2015-2023) ($MN)
Table 35 UROLOGY APPLICATION OF ABLATION DEVICE GLOBAL MARKET, BY REGION(2015-2023) ($MN)
Table 36 ORTHOPEDIC APPLICATION OF ABLATION DEVICE GLOBAL MARKET, BY REGION(2015-2023) ($MN)
Table 37 PAIN MANAGEMENT APPLICATION OF ABLATION DEVICE GLOBAL MARKET, BY REGION(2015-2023) ($MN)
Table 38 OTHER DISEASES APPLICATION OF ABLATION DEVICE GLOBAL MARKET, BY REGION (2015-2023) ($MN)
Table 39 ABLATION DEVICE GLOBAL MARKET REVENUE, BY END-USER, (2015-2023) ($MN)
Table 40 HOSPITALS IN ABLATION DEVICE ENDUSERS GLOBAL MARKET REVENUE, BY REGION, (2015-2023) ($MN)
Table 41 AMBULATORY SURGICAL CENTRE IN ABLATION DEVICE GLOBAL MARKET REVENUE, BY REGION, (2015-2023) ($MN)
Table 42 SPECIALITY CLINICS IN ABLATION DEVICE END USERS GLOBAL MARKET REVENUE, BY REGION, (2015-2023) ($MN)
Table 43 ABLATION DEVICE GLOBAL MARKET REVENUE, BY REGION, (2015-2023) ($MN)
Table 44 NORTH AMERICA ABLATION DEVICE MARKET REVENUE, BY TECHNOLOGY, (2015-2023) ($MN)
Table 45 NORTH AMERICAN THERMAL TECHNOLOGY ABLATION DEVICE MARKET REVENUE, BY TYPE (2015-2023) ($MN)
Table 46 NORTH AMERICAN NON THERMAL TECHNOLOGY ABLATION DEVICE MARKET REVENUE, BY TYPE (2015-2023) ($MN)
Table 47 NORTH AMERICAN ABLATION DEVICE MARKET REVENUE, BY APPLICATION, (2015-2023) ($MN)
Table 48 NORTH AMERICAN ABLATION DEVICE MARKET REVENUE, BY END USERS, (2015-2023) ($MN)
Table 49 EUROPE ABLATION DEVICE MARKET REVENUE, BY TECHNOLOGY, (2015-2023) ($MN)
Table 50 EUROPE THERMAL TECHNOLOGY ABLATION DEVICE MARKET REVENUE, BY TYPE (2015-2023) ($MN)
Table 51 EUROPE NON THERMAL TECHNOLOGY ABLATION DEVICE MARKET REVENUE, BY TYPE (2015-2023) ($MN)
Table 52 EUROPE ABLATION DEVICE MARKET REVENUE, BY APPLICATION, (2015-2023) ($MN)
Table 53 EUROPE ABLATION DEVICE MARKET REVENUE, BY END USERS, (2015-2023) ($MN)
Table 54 ASIA PACIFIC ABLATION DEVICE MARKET REVENUE, BY TECHNOLOGY, (2015-2023) ($MN)
Table 55 ASIA PACIFIC THERMAL TECHNOLOGY ABLATION DEVICE MARKET REVENUE, BY TYPE (2015-2023) ($MN)
Table 56 ASIA PACIFIC NON THERMAL TECHNOLOGY ABLATION DEVICE MARKET REVENUE, BY TYPE (2015-2023) ($MN)
Table 57 ASIA PACIFIC ABLATION DEVICE MARKET REVENUE, BY APPLICATION, (2015-2023) ($MN)
Table 58 ASIA PACIFIC ABLATION DEVICE MARKET REVENUE, BY END USERS, (2015-2023) ($MN)
Table 59 ROW ABLATION DEVICE MARKET REVENUE, BY TECHNOLOGY, (2015-2023) ($MN)
Table 60 ROW THERMAL TECHNOLOGY ABLATION DEVICE MARKET REVENUE, BY TYPE (2015-2023) ($MN)
Table 61 ROW NON-THERMAL TECHNOLOGY ABLATION DEVICE MARKET REVENUE, BY TYPE (2015-2023) ($MN)
Table 62 ROW ABLATION DEVICE MARKET REVENUE, BY APPLICATION, (2015-2023) ($MN)
Table 63 ROW ABLATION DEVICE MARKET REVENUE, BY END USERS, (2015-2023) ($MN)
Table 64 MERGERS AND ACQUITIONS (2015-2016)
Table 65 APPROVALS (2015-2016)
Table 66 NEW PRODUCT LAUNCH (2015-2016)
Table 67 AGREEMENTS, PARTNERSHIPS, COLLABORATIONS & JOINT VENTURES (2015-2016)
Table 68 BUSINESS EXPANSION (2015-2016)
Table 69 ABBOTT LABORATORIES: TOTAL REVENUE AND R&D EXPENSES, (2014-2016) ($MN)
Table 70 ABBOTT LABORATORIES: TOTAL REVENUE, BY SEGMENTS, (2014-2016) ($MN)
Table 71 ABBOTT LABORATORIES: TOTAL REVENUE, BY GEOGRAPHY, (2014-2016) ($MN)
Table 72 ANGIODYNAMICS INC: TOTAL REVENUE AND R&D EXPENSES, (2014-2016) ($MN)
Table 73 ANGIODYNAMICS INC: TOTAL REVENUE, BY SEGMENTS, (2014-2016) ($MN)
Table 74 ANGIODYNAMICS INC: TOTAL REVENUE, BY GEOGRAPHY, (2014-2016) ($MN)
Table 75 ARTICURE INC: TOTAL REVENUE AND R&D EXPENSES, (2014-2016) ($MN)
Table 76 ARTICURE INC: TOTAL REVENUE, BY SEGMENTS, (2014-2016) ($MN)
Table 77 ARTICURE INC: TOTAL REVENUE, BY GEOGRAPHY, (2014-2016) ($MN)
Table 78 BOSTON SCIENTIFIC CORPORATION: TOTAL REVENUE AND R&D EXPENSES, (2014-2016) ($MN)
Table 79 BOSTON SCIENTIFIC CORPORATION: TOTAL REVENUE, BY SEGMENTS, (2014-2016) ($MN)
Table 80 BOSTON SCIENTIFIC CORPORATION: TOTAL REVENUE, BY GEOGRAPHY, (2014-2016) ($MN)
Table 81 CONMED CORPORATION: TOTAL REVENUE AND R&D EXPENSES, (2014-2016) ($MN)
Table 82 CONMED CORPORATION: TOTAL REVENUE, BY SEGMENTS, (2014-2016) ($MN)
Table 83 CONMED CORPORATION: TOTAL REVENUE, BY GEOGRAPHY, (2014-2016) ($MN)
Table 84 ELEKTA AB: TOTAL REVENUE AND R&D EXPENSES, (2014-2016) ($MN)
Table 85 ELEKTA AB: TOTAL REVENUE, BY SEGMENTS (2014-2016) ($MN)
Table 86 ELEKTA AB: TOTAL REVENUE, BY GEOGRAPHY (2014-2016) ($MN)
Table 87 HOLOGIC INC.: TOTAL REVENUE AND R&D EXPENSES, (2014-2016) ($MN)
Table 88 HOLOGIC INC: TOTAL REVENUE, BY SEGMENTS, (2014-2016) ($MN)
Table 89 HOLOGIC INC: TOTAL REVENUE, BY GEOGRAPHY, (2014-2016) ($MN)
Table 90 JOHNSON & JOHNSON: TOTAL REVENUE AND R&D EXPENSES, (2014-2016) ($MN)
Table 91 JOHNSON & JOHNSON: TOTAL REVENUE, BY SEGMENTS, (2014-2016) ($MN)
Table 92 JOHNSON & JOHNSON: TOTAL REVENUE, BY GEOGRAPHY, (2014-2016) ($MN)
Table 93 MEDTRONIC, PLC: TOTAL REVENUE AND R&D EXPENSES, (2014-2016) ($MN)
Table 94 MEDTRONIC, PLC: TOTAL REVENUE, BY SEGMENTS, (2014-2016) ($MN)
Table 95 MEDTRONIC, PLC: CARDIAC AND VASCULAR GROUP REVENUE, BY SUB-SEGMENTS, (2014-2016) ($MN)
Table 96 MEDTRONIC, PLC: MINIMALLY INVASIVE THERAPIES REVENUE, BY SUB-SEGMENTS, (2014-2016) ($MN)
Table 97 MEDTRONIC, PLC: RESTORATIVE THERAPIES GROUP REVENUE, BY SUB-SEGMENTS, (2014-2016) ($MN)
Table 98 MEDTRONIC, PLC: TOTAL REVENUE, BY GEOGRAPHY, (2014-2016) ($MN)
Table 99 OLYMPUS CORPORATION: TOTAL REVENUE AND R&D EXPENSES (2014-2016) ($MN)
Table 100 OLYMPUS CORPORATION: TOTAL REVENUE, BY SEGMENTS (2014-2016) ($MN)
Table 101 OLYMPUS CORPORATION: TOTAL REVENUE, BY GEOGRAPHY (2014-2016) ($MN)
Table 102 SMITH & NEPHEW PLC: TOTAL REVENUE AND R&D EXPENSES, (2014-2016) ($MN)
Table 103 SMITH & NEPHEW PLC: TOTAL REVENUE, BY SEGMENTS, (2014-2016) ($MN)
Table 104 SMITH & NEPHEW PLC: TOTAL REVENUE, BY GEOGRAPHY, (2014-2016) ($MN)
Table 105 STRYKER CORPORATION: TOTAL REVENUE AND R&D EXPENSES, (2014-2016) ($MN)
Table 106 STRYKER CORPORATION: TOTAL REVENUE, BY SEGMENTS, (2014-2016) ($MN)
Table 107 STRYKER CORPORATION: TOTAL NEUROTECHNOLOGY AND SPINE REVENUE, BY SEGMENTS, (2014-2016) ($MN)
Table 108 STRYKER CORPORATION: TOTAL MEDSURG REVENUE, BY SEGMENTS, (2014-2016) ($MN)
Table 109 STRYKER CORPORATION: TOTAL REVENUE, BY GEOGRAPHY, (2014-2016) ($MN)
Table 110 VARIAN MEDICAL SYSTEMS: TOTAL REVENUE AND R&D EXPENSES, (2014-2016) ($MN)
Table 111 VARIAN MEDICAL SYSTEMS: TOTAL REVENUE, BY SEGMENTS, (2014-2016) ($MN)
Table 112 VARIAN MEDICAL SYSTEMS: TOTAL REVENUE, BY GEOGRAPHY, (2014-2016) ($MN)
Table 1 ABLATION DEVICES GLOBAL MARKET REVENUE, BY REGION, (2015-2023) ($MN)
Table 2 ABLATION DEVICES GLOBAL MARKET REVENUE, BY TECHNOLOGY, (2015-2023) ($MN)
Table 3 ABLATION DEVICES GLOBAL MARKET, BY APPLICATION (2015-2023) ($MN)
Table 4 ABLATION DEVICES GLOBAL MARKET REVENUE, BY END-USER, (2015-2023) ($MN)
Table 5 ABLATION DEVICE TECHNIQUES GLOBAL MARKET REVENUE, BY REGION, (2015-2023) ($MN)
Table 6 ABLATION DEVICE GLOBAL MARKET REVENUE, BY TECHNOLOGY, (2015-2023) ($MN)
Table 7 THERMAL TECHNOLOGY IN ABLATION DEVICE GLOBAL MARKET REVENUE, BY REGION, (2015-2023) ($MN)
Table 8 THERMAL TECHNOLOGY IN ABLATION DEVICE GLOBAL MARKET REVENUE, BY TYPES, (2015-2023) ($MN)
Table 9 RADIOFREQUENCY TECHNOLOGY IN ABLATION DEVICE GLOBAL MARKET REVENUE, BY REGION, (2015-2023) ($MN)
Table 10 LASER TECHNOLOGY IN ABLATION DEVICE GLOBAL MARKET REVENUE, BY REGION, (2015-2023) ($MN)
Table 11 MICROWAVE TECHNOLOGY IN ABLATION DEVICE GLOBAL MARKET REVENUE, BY REGION, (2015-2023) ($MN)
Table 12 ULTRASOUND TECHNOLOGY IN ABLATION DEVICE GLOBAL MARKET REVENUE, BY REGION, (2015-2023) ($MN)
Table 13 RADIATION TECHNOLOGY IN ABLATION DEVICE GLOBAL MARKET REVENUE, BY REGION, (2015-2023) ($MN)
Table 14 CRYOABLATION TECHNOLOGY IN ABLATION DEVICE GLOBAL MARKET REVENUE, BY REGION, (2015-2023) ($MN)
Table 15 HYDROTHERMAL TECHNOLOGY IN ABLATION DEVICE GLOBAL MARKET REVENUE, BY REGION, (2015-2023) ($MN)
Table 16 NON-THERMAL TECHNOLOGY IN ABLATION DEVICE GLOBAL MARKET REVENUE, BY REGION, (2015-2023) ($MN)
Table 17 NON-THERMAL TECHNOLOGY IN ABLATION DEVICE GLOBAL MARKET REVENUE, BY TYPE, (2015-2023) ($MN)
Table 18 ELECTROPORATION TECHNOLOGY IN ABLATION DEVICE GLOBAL MARKET REVENUE, BY REGION, (2015-2023) ($MN)
Table 19 MECHANICAL TECHNOLOGY IN ABLATION DEVICE GLOBAL MARKET REVENUE, BY REGION, (2015-2023) ($MN)
Table 20 OTHER NON-THERMAL TECHNOLOGIES IN ABLATION DEVICE GLOBAL MARKET REVENUE, BY REGION, (2015-2023) ($MN)
Table 21 ABLATION DEVICES GLOBAL MARKET, BY APPLICATION (2015-2023) ($MN)
Table 22 ONCOLOGY APPLICATION OF ABLATION DEVICE GLOBAL MARKET REVENUE, BY REGION, (2015-2023) ($MN)
Table 23 CARDIOVASCULAR APPLICATION OF ABLATION DEVICE GLOBAL MARKET REVENUE, BY REGION, (2015-2023) ($MN)
Table 24 CARDIOVASCULAR APPLICATION OF ABLATION DEVICE GLOBAL MARKET, BY TYPES(2015-2023) ($MN)
Table 25 ATRIAL FIBRILATION ABLATION DEVICE GLOBAL MARKET REVENUE, BY REGION, (2015-2023) ($MN)
Table 26 ATRIAL FIBRILATION PROCEDURAL VOLUME GLOBAL MARKET, BY REGION, (2015-2023) (NO'S)
Table 27 VENTRICULAR TACHYCARDIA ABLATION DEVICE GLOBAL MARKET REVENUE, BY REGION, (2015-2023) ($MN)
Table 28 VENTRICULAR TACHYCARDIA PROCEDURAL VOLUME GLOBAL MARKET, BY REGION, (2015-2023) (NO'S)
Table 29 OTHER CARDIOVASCULAR ABLATION DEVICE GLOBAL MARKET REVENUE, BY REGION, (2015-2023) ($MN)
Table 30 OTHER CARDIOVASULAR PROCEDURAL VOLUME GLOBAL MARKET, BY REGION, (2015-2023) (NO'S)
Table 31 OPHTHALMOLOGY APPLICATION OF ABLATION DEVICE GLOBAL MARKET REVENUE, BY REGION, (2015-2023) ($MN)
Table 32 COSMETOLOGY APPLICATION OF ABLATION DEVICE GLOBAL MARKET REVENUE, BY REGION, (2015-2023) ($MN)
Table 33 GYNECOLOGY APPLICATION OF ABLATION DEVICE GLOBAL MARKET, BY REGION (2015-2023) ($MN)
Table 34 GENERAL SURGERY APPLICATION OF ABLATION DEVICE GLOBAL MARKET, BY REGION (2015-2023) ($MN)
Table 35 UROLOGY APPLICATION OF ABLATION DEVICE GLOBAL MARKET, BY REGION(2015-2023) ($MN)
Table 36 ORTHOPEDIC APPLICATION OF ABLATION DEVICE GLOBAL MARKET, BY REGION(2015-2023) ($MN)
Table 37 PAIN MANAGEMENT APPLICATION OF ABLATION DEVICE GLOBAL MARKET, BY REGION(2015-2023) ($MN)
Table 38 OTHER DISEASES APPLICATION OF ABLATION DEVICE GLOBAL MARKET, BY REGION (2015-2023) ($MN)
Table 39 ABLATION DEVICE GLOBAL MARKET REVENUE, BY END-USER, (2015-2023) ($MN)
Table 40 HOSPITALS IN ABLATION DEVICE ENDUSERS GLOBAL MARKET REVENUE, BY REGION, (2015-2023) ($MN)
Table 41 AMBULATORY SURGICAL CENTRE IN ABLATION DEVICE GLOBAL MARKET REVENUE, BY REGION, (2015-2023) ($MN)
Table 42 SPECIALITY CLINICS IN ABLATION DEVICE END USERS GLOBAL MARKET REVENUE, BY REGION, (2015-2023) ($MN)
Table 43 ABLATION DEVICE GLOBAL MARKET REVENUE, BY REGION, (2015-2023) ($MN)
Table 44 NORTH AMERICA ABLATION DEVICE MARKET REVENUE, BY TECHNOLOGY, (2015-2023) ($MN)
Table 45 NORTH AMERICAN THERMAL TECHNOLOGY ABLATION DEVICE MARKET REVENUE, BY TYPE (2015-2023) ($MN)
Table 46 NORTH AMERICAN NON THERMAL TECHNOLOGY ABLATION DEVICE MARKET REVENUE, BY TYPE (2015-2023) ($MN)
Table 47 NORTH AMERICAN ABLATION DEVICE MARKET REVENUE, BY APPLICATION, (2015-2023) ($MN)
Table 48 NORTH AMERICAN ABLATION DEVICE MARKET REVENUE, BY END USERS, (2015-2023) ($MN)
Table 49 EUROPE ABLATION DEVICE MARKET REVENUE, BY TECHNOLOGY, (2015-2023) ($MN)
Table 50 EUROPE THERMAL TECHNOLOGY ABLATION DEVICE MARKET REVENUE, BY TYPE (2015-2023) ($MN)
Table 51 EUROPE NON THERMAL TECHNOLOGY ABLATION DEVICE MARKET REVENUE, BY TYPE (2015-2023) ($MN)
Table 52 EUROPE ABLATION DEVICE MARKET REVENUE, BY APPLICATION, (2015-2023) ($MN)
Table 53 EUROPE ABLATION DEVICE MARKET REVENUE, BY END USERS, (2015-2023) ($MN)
Table 54 ASIA PACIFIC ABLATION DEVICE MARKET REVENUE, BY TECHNOLOGY, (2015-2023) ($MN)
Table 55 ASIA PACIFIC THERMAL TECHNOLOGY ABLATION DEVICE MARKET REVENUE, BY TYPE (2015-2023) ($MN)
Table 56 ASIA PACIFIC NON THERMAL TECHNOLOGY ABLATION DEVICE MARKET REVENUE, BY TYPE (2015-2023) ($MN)
Table 57 ASIA PACIFIC ABLATION DEVICE MARKET REVENUE, BY APPLICATION, (2015-2023) ($MN)
Table 58 ASIA PACIFIC ABLATION DEVICE MARKET REVENUE, BY END USERS, (2015-2023) ($MN)
Table 59 ROW ABLATION DEVICE MARKET REVENUE, BY TECHNOLOGY, (2015-2023) ($MN)
Table 60 ROW THERMAL TECHNOLOGY ABLATION DEVICE MARKET REVENUE, BY TYPE (2015-2023) ($MN)
Table 61 ROW NON-THERMAL TECHNOLOGY ABLATION DEVICE MARKET REVENUE, BY TYPE (2015-2023) ($MN)
Table 62 ROW ABLATION DEVICE MARKET REVENUE, BY APPLICATION, (2015-2023) ($MN)
Table 63 ROW ABLATION DEVICE MARKET REVENUE, BY END USERS, (2015-2023) ($MN)
Table 64 MERGERS AND ACQUITIONS (2015-2016)
Table 65 APPROVALS (2015-2016)
Table 66 NEW PRODUCT LAUNCH (2015-2016)
Table 67 AGREEMENTS, PARTNERSHIPS, COLLABORATIONS & JOINT VENTURES (2015-2016)
Table 68 BUSINESS EXPANSION (2015-2016)
Table 69 ABBOTT LABORATORIES: TOTAL REVENUE AND R&D EXPENSES, (2014-2016) ($MN)
Table 70 ABBOTT LABORATORIES: TOTAL REVENUE, BY SEGMENTS, (2014-2016) ($MN)
Table 71 ABBOTT LABORATORIES: TOTAL REVENUE, BY GEOGRAPHY, (2014-2016) ($MN)
Table 72 ANGIODYNAMICS INC: TOTAL REVENUE AND R&D EXPENSES, (2014-2016) ($MN)
Table 73 ANGIODYNAMICS INC: TOTAL REVENUE, BY SEGMENTS, (2014-2016) ($MN)
Table 74 ANGIODYNAMICS INC: TOTAL REVENUE, BY GEOGRAPHY, (2014-2016) ($MN)
Table 75 ARTICURE INC: TOTAL REVENUE AND R&D EXPENSES, (2014-2016) ($MN)
Table 76 ARTICURE INC: TOTAL REVENUE, BY SEGMENTS, (2014-2016) ($MN)
Table 77 ARTICURE INC: TOTAL REVENUE, BY GEOGRAPHY, (2014-2016) ($MN)
Table 78 BOSTON SCIENTIFIC CORPORATION: TOTAL REVENUE AND R&D EXPENSES, (2014-2016) ($MN)
Table 79 BOSTON SCIENTIFIC CORPORATION: TOTAL REVENUE, BY SEGMENTS, (2014-2016) ($MN)
Table 80 BOSTON SCIENTIFIC CORPORATION: TOTAL REVENUE, BY GEOGRAPHY, (2014-2016) ($MN)
Table 81 CONMED CORPORATION: TOTAL REVENUE AND R&D EXPENSES, (2014-2016) ($MN)
Table 82 CONMED CORPORATION: TOTAL REVENUE, BY SEGMENTS, (2014-2016) ($MN)
Table 83 CONMED CORPORATION: TOTAL REVENUE, BY GEOGRAPHY, (2014-2016) ($MN)
Table 84 ELEKTA AB: TOTAL REVENUE AND R&D EXPENSES, (2014-2016) ($MN)
Table 85 ELEKTA AB: TOTAL REVENUE, BY SEGMENTS (2014-2016) ($MN)
Table 86 ELEKTA AB: TOTAL REVENUE, BY GEOGRAPHY (2014-2016) ($MN)
Table 87 HOLOGIC INC.: TOTAL REVENUE AND R&D EXPENSES, (2014-2016) ($MN)
Table 88 HOLOGIC INC: TOTAL REVENUE, BY SEGMENTS, (2014-2016) ($MN)
Table 89 HOLOGIC INC: TOTAL REVENUE, BY GEOGRAPHY, (2014-2016) ($MN)
Table 90 JOHNSON & JOHNSON: TOTAL REVENUE AND R&D EXPENSES, (2014-2016) ($MN)
Table 91 JOHNSON & JOHNSON: TOTAL REVENUE, BY SEGMENTS, (2014-2016) ($MN)
Table 92 JOHNSON & JOHNSON: TOTAL REVENUE, BY GEOGRAPHY, (2014-2016) ($MN)
Table 93 MEDTRONIC, PLC: TOTAL REVENUE AND R&D EXPENSES, (2014-2016) ($MN)
Table 94 MEDTRONIC, PLC: TOTAL REVENUE, BY SEGMENTS, (2014-2016) ($MN)
Table 95 MEDTRONIC, PLC: CARDIAC AND VASCULAR GROUP REVENUE, BY SUB-SEGMENTS, (2014-2016) ($MN)
Table 96 MEDTRONIC, PLC: MINIMALLY INVASIVE THERAPIES REVENUE, BY SUB-SEGMENTS, (2014-2016) ($MN)
Table 97 MEDTRONIC, PLC: RESTORATIVE THERAPIES GROUP REVENUE, BY SUB-SEGMENTS, (2014-2016) ($MN)
Table 98 MEDTRONIC, PLC: TOTAL REVENUE, BY GEOGRAPHY, (2014-2016) ($MN)
Table 99 OLYMPUS CORPORATION: TOTAL REVENUE AND R&D EXPENSES (2014-2016) ($MN)
Table 100 OLYMPUS CORPORATION: TOTAL REVENUE, BY SEGMENTS (2014-2016) ($MN)
Table 101 OLYMPUS CORPORATION: TOTAL REVENUE, BY GEOGRAPHY (2014-2016) ($MN)
Table 102 SMITH & NEPHEW PLC: TOTAL REVENUE AND R&D EXPENSES, (2014-2016) ($MN)
Table 103 SMITH & NEPHEW PLC: TOTAL REVENUE, BY SEGMENTS, (2014-2016) ($MN)
Table 104 SMITH & NEPHEW PLC: TOTAL REVENUE, BY GEOGRAPHY, (2014-2016) ($MN)
Table 105 STRYKER CORPORATION: TOTAL REVENUE AND R&D EXPENSES, (2014-2016) ($MN)
Table 106 STRYKER CORPORATION: TOTAL REVENUE, BY SEGMENTS, (2014-2016) ($MN)
Table 107 STRYKER CORPORATION: TOTAL NEUROTECHNOLOGY AND SPINE REVENUE, BY SEGMENTS, (2014-2016) ($MN)
Table 108 STRYKER CORPORATION: TOTAL MEDSURG REVENUE, BY SEGMENTS, (2014-2016) ($MN)
Table 109 STRYKER CORPORATION: TOTAL REVENUE, BY GEOGRAPHY, (2014-2016) ($MN)
Table 110 VARIAN MEDICAL SYSTEMS: TOTAL REVENUE AND R&D EXPENSES, (2014-2016) ($MN)
Table 111 VARIAN MEDICAL SYSTEMS: TOTAL REVENUE, BY SEGMENTS, (2014-2016) ($MN)
Table 112 VARIAN MEDICAL SYSTEMS: TOTAL REVENUE, BY GEOGRAPHY, (2014-2016) ($MN)
LIST OF FIGURES
Figure 1 ABLATION DEVICE GLOBAL MARKET SHARE, BY GEOGRAPHY (2015-2023)
Figure 2 RESEARCH METHODOLOGY: ABLATION DEVICE GLOBAL MARKET
Figure 3 ABLATION DEVICE GLOBAL MARKET: TOP-DOWN AND BOTTOM-UP APPROACH
Figure 4 ABLATION DEVICE GLOBAL MARKET: FORECASTING MODEL
Figure 5 ABLATION DEVICE GLOBAL MARKET: MARKET BREAKDOWN & DATA TRIANGULATION
Figure 6 ABLATION DEVICES GLOBAL MARKET: MARKET SEGMENTATION
Figure 7 MARKET DYNAMICS
Figure 8 ABLATION DEVICES MARKET:PATENT FILING BY MAJOR PLAYERS (2011-2016)
Figure 9 ABLATION DEVICE GLOBAL MARKET: SUPPLY CHAIN ANALYSIS
Figure 10 ABLATION DEVICES GLOBAL MARKET: PORTER’S ANALYSIS
Figure 11 ABLATION DEVICE GLOBAL MARKET SHARE ANALYSIS, BY KEY PLAYERS, (2016)
Figure 12 ATRIAL FIBRILLATION ABLATION DEVICE GLOBAL MARKET SHARE ANALYSIS, BY KEY PLAYERS, 2016
Figure 13 RADIATION TECHNOLOGY ABLATION DEVICE GLOBAL MARKET SHARE ANALYSIS, BY KEY PLAYERS, (2016)
Figure 14 ABLATION DEVICE GLOBAL MARKET REVENUE, BY TECHNOLOGY (2015-2023) ($MN)
Figure 15 THERMAL TECHNOLOGY IN ABLATION DEVICE TECHNOLOGY GLOBAL MARKET REVENUE, BY TYPES (2016) ($MN)
Figure 16 RADIOFREQUENCY ABLATION DEVICE GLOBAL MARKET SHARE, BY APPLICATION (2016) (%)
Figure 17 LASER ABLATION DEVICE GLOBAL MARKET SHARE, BY APPLICATION (2016) (%)
Figure 18 THERMAL TECHNOLOGY IN ABLATION DEVICE GLOBAL MARKET REVENUE, MICROWAVE APPLICATION MARKET SHARE (2016) (%)
Figure 19 ULTRASOUND ABLATION DEVICE GLOBAL MARKET SHARE, BY APPLICATION (2016) (%)
Figure 20 RADIATION ABLATION DEVICE GLOBAL MARKET SHARE, BY APPLICATION (2016) (%)
Figure 21 THERMAL TECHNOLOGY IN ABLATION DEVICE GLOBAL MARKET REVENUE, CRYOABLATION APPLICATION MARKET SHARE (2016) (%)
Figure 22 NON-THERMAL TECHNOLOGY IN ABLATION DEVICE GLOBAL MARKET REVENUE, BY TYPE (2016 V’S 2023) ($MN)
Figure 23 ABLATION DEVICE GLOBAL MARKET SHARE, BY APPLICATIONS, (2016) (%)
Figure 24 CANCER ABLATION PROCEDURE VOLUME, BY DISEASE TYPES, (2016) (%)
Figure 25 ABLATION DEVICE GLOBAL MARKET REVENUE, BY END USERS (2015-2023) ($MN)
Figure 26 ABLATION DEVICE GLOBAL MARKET REVENUE, BY REGION (2015-2023) CAGR (%)
Figure 27 OUTLOOK OF NORTH AMERICA ABLATION DEVICE MARKET, BY TECHNOLOGY (2016 V’S 2023) ($MN)
Figure 28 OUTLOOK OF NORTH AMERICA ABLATION DEVICE MARKET, BY APPLICATIONS & END USERS (2016 V’S 2023) ($MN)
Figure 29 OUTLOOK OF U.S. ABLATION DEVICE MARKET, BY TECHNOLOGY, APPLICATION & END USERS (2016 V’S 2023) ($MN)
Figure 30 OUTLOOK OF OTHER NORTH AMERICAN ABLATION DEVICE MARKET, BY APPLICATIONS, TECHNIQUES & END-USERS (2016 V’S 2023) ($MN)
Figure 31 OUTLOOK OF EUROPE ABLATION DEVICE MARKET, BY TECHNOLOGY (2016 V’S 2023) ($MN)
Figure 32 OUTLOOK OF EUROPE ABLATION DEVICE MARKET, BY APPLICATION & END USERS (2016 V’S 2023) ($MN)
Figure 33 OUTLOOK OF U.K. ABLATION DEVICE MARKET, BY TECHNOLOGY, APPLICATION & END USERS (2016 V’S 2023) ($MN)
Figure 34 OUTLOOK OF GERMANY ABLATION DEVICE MARKET, BY TECHNOLOGY, APPLICATION & END USERS (2016 V’S 2023) ($MN)
Figure 35 OUTLOOK OF FRANCE ABLATION DEVICE MARKET, BY TECHNOLOGY, APPLICATION & END USERS (2016 V’S 2023) ($MN)
Figure 36 OUTLOOK OF OTHER EUROPEAN ABLATION DEVICE MARKET, BY TECHNOLOGY, APPLICATIONS, & END-USERS (2016 V’S 2023) ($MN)
Figure 37 OUTLOOK OF ASIA-PACIFIC ABLATION DEVICE MARKET, BY TECHNOLOGY (2016 V’S 2023) ($MN)
Figure 38 OUTLOOK OF ASIA-PACIFIC ABLATION DEVICE MARKET, BY APPLICATION AND END USERS (2016 V’S 2023) ($MN)
Figure 39 OUTLOOK OF INDIA ABLATION DEVICE MARKET, BY TECHNOLOGY, APPLICATION & END USERS (2016 V’S 2023) ($MN)
Figure 40 OUTLOOK OF CHINA ABLATION DEVICE MARKET, BY TECHNOLOGY, APPLICATION & END USERS (2016 V’S 2023) ($MN)
Figure 41 OUTLOOK OF JAPAN ABLATION DEVICE MARKET, BY TECHNOLOGY, APPLICATION & END USERS (2016 V’S 2023) ($MN)
Figure 42 OUTLOOK OF OTHER ASIA PACIFIC ABLATION DEVICE MARKET, BY TECHNOLOGY, APPLICATIONS & END-USERS (2016 V’S 2023) ($MN)
Figure 43 OUTLOOK OF ROW ABLATION DEVICE MARKET REVENUE, BY TECHNOLOGY (2016 V’S 2023) ($MN)
Figure 44 OUTLOOK OF ROW ABLATION DEVICE MARKET, BY APPLICATION & END-USERS (2016 V’S 2023) ($MN)
Figure 45 OUTLOOK OF MIDDLE EAST ABLATION DEVICE MARKET, BY TECHNOLOGY, APPLICATION & ENDUSERS (2016 V’S 2023) ($MN)
Figure 46 OUTLOOK OF BRAZIL ABLATION DEVICE MARKET, BY TECHNOLOGY, APPLICATION & END USERS (2016 V’S 2023) ($MN)
Figure 47 OUTLOOK OF OTHER ROW REGION ABLATION DEVICE MARKET, BY TECHNOLOGY, APPLICATION & ENDUSER (2016 V’S 2023) ($MN)
Figure 48 KEY GROWTH STRATEGIES (2015-2016)
Figure 49 SWOT: ABBOTT LABORATORIES
Figure 50 SWOT: ANGIODYNAMICS
Figure 51 SWOT: ARTICURE INC
Figure 52 SWOT: BOSTON SCIENTIFIC CORPORATION
Figure 53 SWOT: CONMED CORPORATION
Figure 54 SWOT: ELEKTA AB
Figure 55 SWOT: HOLOGIC INC
Figure 56 SWOT: JOHNSON AND JOHNSON
Figure 57 SWOT: MEDTRONIC PLC
Figure 58 SWOT: OLYMPUS CORPORATION
Figure 59 SWOT: SMITH AND NEPHEW PLC
Figure 60 SWOT: STRYKER CORPORATION
Figure 61 SWOT: VARIAN MEDICAL SYSTEMS
Figure 1 ABLATION DEVICE GLOBAL MARKET SHARE, BY GEOGRAPHY (2015-2023)
Figure 2 RESEARCH METHODOLOGY: ABLATION DEVICE GLOBAL MARKET
Figure 3 ABLATION DEVICE GLOBAL MARKET: TOP-DOWN AND BOTTOM-UP APPROACH
Figure 4 ABLATION DEVICE GLOBAL MARKET: FORECASTING MODEL
Figure 5 ABLATION DEVICE GLOBAL MARKET: MARKET BREAKDOWN & DATA TRIANGULATION
Figure 6 ABLATION DEVICES GLOBAL MARKET: MARKET SEGMENTATION
Figure 7 MARKET DYNAMICS
Figure 8 ABLATION DEVICES MARKET:PATENT FILING BY MAJOR PLAYERS (2011-2016)
Figure 9 ABLATION DEVICE GLOBAL MARKET: SUPPLY CHAIN ANALYSIS
Figure 10 ABLATION DEVICES GLOBAL MARKET: PORTER’S ANALYSIS
Figure 11 ABLATION DEVICE GLOBAL MARKET SHARE ANALYSIS, BY KEY PLAYERS, (2016)
Figure 12 ATRIAL FIBRILLATION ABLATION DEVICE GLOBAL MARKET SHARE ANALYSIS, BY KEY PLAYERS, 2016
Figure 13 RADIATION TECHNOLOGY ABLATION DEVICE GLOBAL MARKET SHARE ANALYSIS, BY KEY PLAYERS, (2016)
Figure 14 ABLATION DEVICE GLOBAL MARKET REVENUE, BY TECHNOLOGY (2015-2023) ($MN)
Figure 15 THERMAL TECHNOLOGY IN ABLATION DEVICE TECHNOLOGY GLOBAL MARKET REVENUE, BY TYPES (2016) ($MN)
Figure 16 RADIOFREQUENCY ABLATION DEVICE GLOBAL MARKET SHARE, BY APPLICATION (2016) (%)
Figure 17 LASER ABLATION DEVICE GLOBAL MARKET SHARE, BY APPLICATION (2016) (%)
Figure 18 THERMAL TECHNOLOGY IN ABLATION DEVICE GLOBAL MARKET REVENUE, MICROWAVE APPLICATION MARKET SHARE (2016) (%)
Figure 19 ULTRASOUND ABLATION DEVICE GLOBAL MARKET SHARE, BY APPLICATION (2016) (%)
Figure 20 RADIATION ABLATION DEVICE GLOBAL MARKET SHARE, BY APPLICATION (2016) (%)
Figure 21 THERMAL TECHNOLOGY IN ABLATION DEVICE GLOBAL MARKET REVENUE, CRYOABLATION APPLICATION MARKET SHARE (2016) (%)
Figure 22 NON-THERMAL TECHNOLOGY IN ABLATION DEVICE GLOBAL MARKET REVENUE, BY TYPE (2016 V’S 2023) ($MN)
Figure 23 ABLATION DEVICE GLOBAL MARKET SHARE, BY APPLICATIONS, (2016) (%)
Figure 24 CANCER ABLATION PROCEDURE VOLUME, BY DISEASE TYPES, (2016) (%)
Figure 25 ABLATION DEVICE GLOBAL MARKET REVENUE, BY END USERS (2015-2023) ($MN)
Figure 26 ABLATION DEVICE GLOBAL MARKET REVENUE, BY REGION (2015-2023) CAGR (%)
Figure 27 OUTLOOK OF NORTH AMERICA ABLATION DEVICE MARKET, BY TECHNOLOGY (2016 V’S 2023) ($MN)
Figure 28 OUTLOOK OF NORTH AMERICA ABLATION DEVICE MARKET, BY APPLICATIONS & END USERS (2016 V’S 2023) ($MN)
Figure 29 OUTLOOK OF U.S. ABLATION DEVICE MARKET, BY TECHNOLOGY, APPLICATION & END USERS (2016 V’S 2023) ($MN)
Figure 30 OUTLOOK OF OTHER NORTH AMERICAN ABLATION DEVICE MARKET, BY APPLICATIONS, TECHNIQUES & END-USERS (2016 V’S 2023) ($MN)
Figure 31 OUTLOOK OF EUROPE ABLATION DEVICE MARKET, BY TECHNOLOGY (2016 V’S 2023) ($MN)
Figure 32 OUTLOOK OF EUROPE ABLATION DEVICE MARKET, BY APPLICATION & END USERS (2016 V’S 2023) ($MN)
Figure 33 OUTLOOK OF U.K. ABLATION DEVICE MARKET, BY TECHNOLOGY, APPLICATION & END USERS (2016 V’S 2023) ($MN)
Figure 34 OUTLOOK OF GERMANY ABLATION DEVICE MARKET, BY TECHNOLOGY, APPLICATION & END USERS (2016 V’S 2023) ($MN)
Figure 35 OUTLOOK OF FRANCE ABLATION DEVICE MARKET, BY TECHNOLOGY, APPLICATION & END USERS (2016 V’S 2023) ($MN)
Figure 36 OUTLOOK OF OTHER EUROPEAN ABLATION DEVICE MARKET, BY TECHNOLOGY, APPLICATIONS, & END-USERS (2016 V’S 2023) ($MN)
Figure 37 OUTLOOK OF ASIA-PACIFIC ABLATION DEVICE MARKET, BY TECHNOLOGY (2016 V’S 2023) ($MN)
Figure 38 OUTLOOK OF ASIA-PACIFIC ABLATION DEVICE MARKET, BY APPLICATION AND END USERS (2016 V’S 2023) ($MN)
Figure 39 OUTLOOK OF INDIA ABLATION DEVICE MARKET, BY TECHNOLOGY, APPLICATION & END USERS (2016 V’S 2023) ($MN)
Figure 40 OUTLOOK OF CHINA ABLATION DEVICE MARKET, BY TECHNOLOGY, APPLICATION & END USERS (2016 V’S 2023) ($MN)
Figure 41 OUTLOOK OF JAPAN ABLATION DEVICE MARKET, BY TECHNOLOGY, APPLICATION & END USERS (2016 V’S 2023) ($MN)
Figure 42 OUTLOOK OF OTHER ASIA PACIFIC ABLATION DEVICE MARKET, BY TECHNOLOGY, APPLICATIONS & END-USERS (2016 V’S 2023) ($MN)
Figure 43 OUTLOOK OF ROW ABLATION DEVICE MARKET REVENUE, BY TECHNOLOGY (2016 V’S 2023) ($MN)
Figure 44 OUTLOOK OF ROW ABLATION DEVICE MARKET, BY APPLICATION & END-USERS (2016 V’S 2023) ($MN)
Figure 45 OUTLOOK OF MIDDLE EAST ABLATION DEVICE MARKET, BY TECHNOLOGY, APPLICATION & ENDUSERS (2016 V’S 2023) ($MN)
Figure 46 OUTLOOK OF BRAZIL ABLATION DEVICE MARKET, BY TECHNOLOGY, APPLICATION & END USERS (2016 V’S 2023) ($MN)
Figure 47 OUTLOOK OF OTHER ROW REGION ABLATION DEVICE MARKET, BY TECHNOLOGY, APPLICATION & ENDUSER (2016 V’S 2023) ($MN)
Figure 48 KEY GROWTH STRATEGIES (2015-2016)
Figure 49 SWOT: ABBOTT LABORATORIES
Figure 50 SWOT: ANGIODYNAMICS
Figure 51 SWOT: ARTICURE INC
Figure 52 SWOT: BOSTON SCIENTIFIC CORPORATION
Figure 53 SWOT: CONMED CORPORATION
Figure 54 SWOT: ELEKTA AB
Figure 55 SWOT: HOLOGIC INC
Figure 56 SWOT: JOHNSON AND JOHNSON
Figure 57 SWOT: MEDTRONIC PLC
Figure 58 SWOT: OLYMPUS CORPORATION
Figure 59 SWOT: SMITH AND NEPHEW PLC
Figure 60 SWOT: STRYKER CORPORATION
Figure 61 SWOT: VARIAN MEDICAL SYSTEMS
